Search Results for: randomized

Fraud by bone researcher takes down two meta-analyses, a clinical trial, and review

The troubles continue for a bone researcher, who’s lost multiple papers in recent months due to problems ranging from data issues to including authors without their consent. Now, journals have retracted two more papers by Yoshihiro Sato. And in a sign of the downstream effects that fraud can have, another journal has retracted two meta-analyses by other … Continue reading Fraud by bone researcher takes down two meta-analyses, a clinical trial, and review

“Strange. Very strange:” Retracted nutrition study reappears in new journal

In an unusual turn of events, a nutrition paper has come back to life a year after being pulled from its original publication. After the paper was retracted from the journal Obesity, the authors revised it and republished it in another journal, Pediatric Obesity. Both journals are published by Wiley. The second version of the paper … Continue reading “Strange. Very strange:” Retracted nutrition study reappears in new journal

Weekend reads: Investigations need sunlight; should we name fraudster names?; how to kill predatory journals

The week at Retraction Watch featured a lawsuit threat following criticism of a popular education program, and the new editor of PLOS ONE’s explanation of why submissions are down. Here’s what was happening elsewhere:

Got “significosis?” Here are the five diseases of academic publishing

John Antonakis is psychologist by training, but his research has run the gamut from showing kids accurately predict election outcomes just by looking at candidates’ faces to teaching charisma to people in leadership positions. Now, as the newly appointed editor of The Leadership Quarterly, he’s tackling problems in academic publishing. But his approach is somewhat … Continue reading Got “significosis?” Here are the five diseases of academic publishing

Authors retract two statin papers, one with problems “too extensive to revise”

Researchers in China have retracted two 2016 papers about the possible use of a cholesterol-lowering agent to treat bleeding on the brain. One of the retracted papers in the Journal of Neurosurgery (JNS) had multiple problems that were “too extensive to revise,” according to the lengthy retraction notice, relating to issues with authorship, data analyses, … Continue reading Authors retract two statin papers, one with problems “too extensive to revise”

Co-author of retraction record-holder likely fabricated his own data, analysis shows

In 2012, John Carlisle, a British anesthesiologist, demonstrated conclusively using statistics that Yoshitaka Fujii had faked data in many studies. Fujii — as followers of this blog well know — now holds the record for most retractions by an individual author (183). Carlisle’s work accomplished two things: It put to rest any doubt that problems … Continue reading Co-author of retraction record-holder likely fabricated his own data, analysis shows

Weekend reads: Jail for scientific fraud?; data-sharing horrors; the lighter side of retractions

The week at Retraction Watch featured the retraction of a physics society’s press release quoting U.S. president-elect Donald Trump, and an apparent blow for clairvoyance research. Here’s what was happening elsewhere:

Analysis casts doubt on bone researcher’s body of work

A new analysis of more than 30 clinical trials co-authored by a bone researcher based in Japan is casting doubt on the legitimacy of the findings. Yoshihiro Sato, based at Mitate Hospital, has already retracted 12 papers, for reasons ranging from data problems, to including co-authors without their consent, to self-plagiarism. Most of these retracted papers are … Continue reading Analysis casts doubt on bone researcher’s body of work

Second paper about major blood pressure drug trial in Japan to be retracted

A second paper about a major randomized trial in Japanese patients with heart disease is being retracted, after an investigation reportedly found multiple problems with the paper. As predicted by Pharma Japan, Hypertension Research is retracting a 2011 paper, already the subject of two errata. Although a spokesperson said she couldn’t say why the paper was being retracted, as … Continue reading Second paper about major blood pressure drug trial in Japan to be retracted

Reviewers may rate papers differently when blinded to authors’ identities, new study says

Although previous research has suggested peer reviewers are not influenced by knowing the authors’ identity and affiliation, a new Research Letter published today in JAMA suggests otherwise. In “Single-blind vs Double-blind Peer Review in the Setting of Author Prestige,” Kanu Okike at Kaiser Moanalua Medical Center in Hawaii and his colleagues created a fake manuscript … Continue reading Reviewers may rate papers differently when blinded to authors’ identities, new study says